Get the App
A

Athenex (ATNX)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD

About Athenex (ATNX)

Athenex, Inc. is an oncology pharmaceutical company focused on the development and commercialization of therapies for cancer diseases and supportive therapies. The Company's technology platform is organized into three categories, including Oral Absor... Read more

  • USD1.20
  • USD1.23
  • USD1.15
  • USD23.80
  • -49.30%
  • 103M
  • 47.97k
  • 133.15k
  • 12M
  • 0.98
  • -93.00%

Stock News

Top 50 Perfume Brands in the World

1 hour ago

Top 50 Perfume Brands in the World

Yahoo

: Fiery French protests and widespread Israeli strike reflect discord with democracy. The U.S. is not immune.

1 hour ago

: Fiery French protests and widespread Israeli strike reflect discord with democracy. The U.S. is not immune.

MarketWatch

S&P Global Commodity Insights Launches eWindow® for Asian Biofuels and Feedstock

2 hours ago

S&P Global Commodity Insights Launches eWindow® for Asian Biofuels and Feedstock

Yahoo

Alibaba to decide on control over new business units after IPOs

3 hours ago

Alibaba to decide on control over new business units after IPOs

Reuters

More Stock Analysis & Reports

Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.

Try Premium